Evidence map›Paper›PMID 15983058›Full record

ArticleThe Journal of cell biology2005

Adenovirus E4orf6 targets pp32/LANP to control the fate of ARE-containing mRNAs by perturbing the CRM1-dependent mechanism.

Fumihiro Higashino, Mariko Aoyagi, Akiko Takahashi, Masaho Ishino, Masato Taoka, Toshiaki Isobe, Masanobu Kobayashi, Yasunori Totsuka, Takao Kohgo, Masanobu Shindoh

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Metabolic Control by DNA Tumor Virus-Encoded Proteins.Pathogens (Basel, Switzerland) · 2021
    Review
  4. Article
  5. Article
  6. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered PathogenesisFrontiers in molecular biosciences · 2020
    Article
  7. Article
  8. Review
  9. Article
  10. Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.BioEssays : news and reviews in molecular, cellular and developmental biology · 2014
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Fumihiro HigashinoDepartment of Oral Pathobiological Science, Hokkaido University Graduate School of Dental Medicine, Sapporo 060-8586, Japan. fhigashi@den.hokudai.ac.jp
Mariko Aoyagi
Akiko Takahashi
Masaho Ishino
Masato Taoka
Toshiaki Isobe
Masanobu Kobayashi
Yasunori Totsuka
Takao Kohgo
Masanobu Shindoh
Hokkaido University · JPTokyo Metropolitan University · JPSapporo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

E4orf6 plays an important role in the transportation of cellular and viral mRNAs and is known as an oncogene product of adenovirus. Here, we show that E4orf6 interacts with pp32/leucine-rich acidic nuclear protein (LANP). E4orf6 exports pp32/LANP from the nucleus to the cytoplasm with its binding partner, HuR, which binds to an AU-rich element (ARE) present within many protooncogene and cytokine mRNAs. We found that ARE-mRNAs, such as c-fos, c-myc, and cyclooxygenase-2, were also exported to and stabilized in the cytoplasm of E4orf6-expressing cells. The oncodomain of E4orf6 was necessary for both binding to pp32/LANP and effect for ARE-mRNA. C-fos mRNA was exported together with E4orf6, E1B-55kD, pp32/LANP, and HuR proteins. Moreover, inhibition of the CRM1-dependent export pathway failed to block the export of ARE-mRNAs mediated by E4orf6. Thus, E4orf6 interacts with pp32/LANP to modulate the fate of ARE-mRNAs by altering the CRM1-dependent export pathway.

Indexed as

Active Transport, Cell NucleusAdenoviridaeAdenovirus E1B ProteinsAdenovirus E4 ProteinsAntigens, SurfaceCell LineCell NucleusELAV-Like Protein 1ELAV ProteinsExportin 1 ProteinHumansKaryopherinsNeuropeptidesNuclear ProteinsOpen Reading FramesProtein BindingAdenovirus E1B ProteinsAdenovirus E4 ProteinsAnp32a protein, ratAntigens, SurfaceELAVL1 protein, humanELAV-Like Protein 1ELAV ProteinsExportin 1 ProteinKaryopherinsNeuropeptidesNuclear ProteinsProto-Oncogene Proteins c-fosReceptors, Cytoplasmic and NuclearRNA-Binding ProteinsRNA, MessengerRNA, Viral

Identifiers

PMID15983058
PMCPMC2171388
OpenAlexW2114131857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.